These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Rosito GA; D'Agostino RB; Massaro J; Lipinska I; Mittleman MA; Sutherland P; Wilson PW; Levy D; Muller JE; Tofler GH Thromb Haemost; 2004 Apr; 91(4):683-9. PubMed ID: 15045128 [TBL] [Abstract][Full Text] [Related]
7. Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease. Potze W; Siddiqui MS; Sanyal AJ Semin Thromb Hemost; 2015 Jul; 41(5):488-93. PubMed ID: 26049073 [TBL] [Abstract][Full Text] [Related]
8. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease. Kelleher CC Eur J Epidemiol; 1992 May; 8 Suppl 1():79-82. PubMed ID: 1505657 [TBL] [Abstract][Full Text] [Related]
9. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Primrose JN; Davies JA; Prentice CR; Hughes R; Johnston D Thromb Haemost; 1992 Oct; 68(4):396-9. PubMed ID: 1448769 [TBL] [Abstract][Full Text] [Related]
10. Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study. Scarabin PY; Aillaud MF; Luc G; Lacroix B; Mennen L; Amouyel P; Evans A; Ferrières J; Arveiler D; Juhan-Vague I; Thromb Res; 2001 May; 102(4):285-93. PubMed ID: 11369422 [TBL] [Abstract][Full Text] [Related]
11. Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women. Braunstein JB; Kershner DW; Bray P; Gerstenblith G; Schulman SP; Post WS; Blumenthal RS Chest; 2002 Mar; 121(3):906-20. PubMed ID: 11888977 [TBL] [Abstract][Full Text] [Related]
12. Hemostatic function in young subjects with central obesity: relationship with left ventricular function. Licata G; Scaglione R; Avellone G; Ganguzza A; Corrao S; Arnone S; Di Chiara T Metabolism; 1995 Nov; 44(11):1417-21. PubMed ID: 7476328 [TBL] [Abstract][Full Text] [Related]
13. Hemostatic risk factors of coronary artery disease in the Chinese. Ho CH; Wang SP; Jap TS Int J Cardiol; 1995 Aug; 51(1):79-84. PubMed ID: 8522401 [TBL] [Abstract][Full Text] [Related]
14. Visceral fat as a determinant of fibrinolysis and hemostasis. Mertens I; Van Gaal LF Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580 [TBL] [Abstract][Full Text] [Related]
15. Factor VII and haemostasis. Osterud B Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929 [TBL] [Abstract][Full Text] [Related]
16. Hemostatic gene expression and vascular disease in obesity: insights from studies of genetically obese mice. Samad F; Loskutoff DJ Thromb Haemost; 1999 Aug; 82(2):742-7. PubMed ID: 10605777 [No Abstract] [Full Text] [Related]
17. Association of DEXA-assessed total body fat mass with serum lipids and haemostatic variables. De Lorenzo F; Mukherjee M; Kadziola Z; Kakkar VV Blood Coagul Fibrinolysis; 1998 Apr; 9(3):291-2. PubMed ID: 9663715 [No Abstract] [Full Text] [Related]
18. [From fibrinogen to fibrin and its dissolution]. Juhan-Vague I; Hans M Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455 [TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus as a prothrombotic condition. Grant PJ J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584 [TBL] [Abstract][Full Text] [Related]
20. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Agirbasli M Int J Clin Pract; 2005 Jan; 59(1):102-6. PubMed ID: 15707473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]